Mirai Genomics is a Japan-based biotechnology company specializing in advanced molecular diagnostics and point-of-care (POC) testing solutions. Founded in 2019, the company develops innovative nucleic acid testing systems such as the GenPad, combining laboratory-level PCR accuracy with portability and ease of use. With offices in Japan and Europe, Mirai Genomics aims to make rapid, reliable disease detection accessible worldwide, addressing global health challenges like infectious diseases and antimicrobial resistance.

Full-cycle production in Japan
In-house production of devices, test cartridges, enzymes, polymerases, primers, and other components in accordance with the ISO 13485 highest quality standards.
More than 20 patents
SmartAmp® key technology is a proprietary next generation molecular technology ensuring the highest level of accuracy.

Mirai Genomics

Org chart

Teams

Offices